IL184343A0 - Gitr antibodies for the diagnosis of nsclc - Google Patents

Gitr antibodies for the diagnosis of nsclc

Info

Publication number
IL184343A0
IL184343A0 IL184343A IL18434307A IL184343A0 IL 184343 A0 IL184343 A0 IL 184343A0 IL 184343 A IL184343 A IL 184343A IL 18434307 A IL18434307 A IL 18434307A IL 184343 A0 IL184343 A0 IL 184343A0
Authority
IL
Israel
Prior art keywords
nsclc
diagnosis
gitr antibodies
gitr
antibodies
Prior art date
Application number
IL184343A
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of IL184343A0 publication Critical patent/IL184343A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL184343A 2005-01-19 2007-07-02 Gitr antibodies for the diagnosis of nsclc IL184343A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64534905P 2005-01-19 2005-01-19
PCT/US2006/002050 WO2006078911A2 (en) 2005-01-19 2006-01-19 Gitr antibodies for the diagnosis of nsclc

Publications (1)

Publication Number Publication Date
IL184343A0 true IL184343A0 (en) 2007-10-31

Family

ID=36692925

Family Applications (1)

Application Number Title Priority Date Filing Date
IL184343A IL184343A0 (en) 2005-01-19 2007-07-02 Gitr antibodies for the diagnosis of nsclc

Country Status (8)

Country Link
EP (1) EP1856281A2 (en)
JP (1) JP2008527998A (en)
CN (1) CN101133167A (en)
AU (1) AU2006206343A1 (en)
BR (1) BRPI0606685A2 (en)
CA (1) CA2592330A1 (en)
IL (1) IL184343A0 (en)
WO (1) WO2006078911A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2343320T3 (en) 2005-03-25 2018-01-29 Gitr Inc ANTI-GITR ANTIBODIES AND APPLICATIONS THEREOF
EP2175884B8 (en) 2007-07-12 2017-02-22 GITR, Inc. Combination therapies employing gitr binding molecules
LT3023438T (en) 2009-09-03 2020-05-11 Merck Sharp & Dohme Corp. Anti-gitr antibodies
KR101566539B1 (en) 2012-06-08 2015-11-05 국립암센터 Novel epitope for switching to Th2 cell and use thereof
TW201605896A (en) 2013-08-30 2016-02-16 安美基股份有限公司 GITR antigen binding proteins
SG10201810507WA (en) 2014-06-06 2018-12-28 Bristol Myers Squibb Co Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof
JP5995207B2 (en) * 2014-11-28 2016-09-21 学校法人 学習院 Boron-containing porphyrin derivatives
EA201792497A1 (en) 2015-06-03 2018-05-31 Бристол-Майерс Сквибб Компани ANTIBODIES TO GITR FOR DIAGNOSIS OF MALIGNANT TUMOR
WO2017087678A2 (en) 2015-11-19 2017-05-26 Bristol-Myers Squibb Company Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof
EP3426297A4 (en) * 2016-03-08 2019-08-14 Janssen Biotech, Inc. Gitr antibodies, methods, and uses
WO2018162376A1 (en) * 2017-03-07 2018-09-13 F. Hoffmann-La Roche Ag Method for discovery of alternative antigen specific antibody variants
KR20200006115A (en) 2017-05-16 2020-01-17 브리스톨-마이어스 스큅 컴퍼니 Treatment of Cancer with Anti-GITR Agonist Antibodies
CN109777872B (en) * 2017-11-15 2021-04-02 北京大学 T cell subsets in lung cancer and genes characteristic thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689607B2 (en) * 1997-10-21 2004-02-10 Human Genome Sciences, Inc. Human tumor, necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2
US6503184B1 (en) * 1997-10-21 2003-01-07 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2
US20030138426A1 (en) * 1997-10-21 2003-07-24 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like proteins TR11, TR11SV1, and TR11SV2
JP2001520039A (en) * 1997-10-21 2001-10-30 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド Human tumor necrosis factor receptor-like proteins, TR11, TR11SV1 and TR11SV2
WO2000050459A1 (en) * 1999-02-24 2000-08-31 Human Genome Sciences, Inc. Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2
AU2004245998A1 (en) * 2003-06-04 2004-12-16 The Government of the United States as represented by The Secretary of the Department of Health and Human Services, Centres for Disease Control and Prevention PNI microarray and uses

Also Published As

Publication number Publication date
BRPI0606685A2 (en) 2009-07-14
EP1856281A2 (en) 2007-11-21
CN101133167A (en) 2008-02-27
JP2008527998A (en) 2008-07-31
WO2006078911A2 (en) 2006-07-27
AU2006206343A1 (en) 2006-07-27
CA2592330A1 (en) 2006-07-27
WO2006078911A3 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
IL184343A0 (en) Gitr antibodies for the diagnosis of nsclc
IL254157A0 (en) 14-3-3eta antibodies and uses thereof for the diagnosis and treatment of arthritis
IL188330A0 (en) Processes for the preparation of
IL178823A0 (en) Platelet biomarkers for the detection of disease
HK1244823A1 (en) Antibodies specific for the protofibril form of beta-amyloid protein
PT2343320T (en) Anti-gitr antibodies and uses thereof
SI1973950T1 (en) Anti-ephb4 antibodies and methods using the same
EP1869192A4 (en) Framework-shuffling of antibodies
GB0517487D0 (en) Antibodies
IL185939A0 (en) Preparation of paricalcitol
EP1893625A4 (en) Methods for the preparation of 9-deazapurine derivatives
GB0525541D0 (en) Detection of antibodies
GB0400976D0 (en) Methods of diagnosis
IL187855A0 (en) Processes for the preparation of docetaxel
ZA200710664B (en) Processes for the preparation of docetaxel
EP1896047A4 (en) Anti-gfralpha3 antibodies
GB0505489D0 (en) Antibodies
GB0419199D0 (en) Methods of diagnosis
ITMI20052464A1 (en) PROCEDURE FOR THE PREPARATION OF NORELGESTROMIN NORELGESTROMINA
GB0420873D0 (en) Methods of diagnosis
GB0512278D0 (en) Antibodies
GB0505054D0 (en) Antibodies
HUP0500570A3 (en) Process for the preparation of (s)-(-)-amlodipine
GB0509431D0 (en) Methods of diagnosis
GB0509251D0 (en) Methods of diagnosis